Call for Papers | Cancer Research | American Association for Cancer Research

Call for Papers | Cancer Research | American Association for Cancer Research .aacrcontent ul {list-style-image: url(‘/ImageLibrary/CR/icons/cr_bullet.png’);} .banner{ display: block; width: 100% margin: -20px; } .banner-sm{ display: none; } h3 { margin-top: 22px; } .aacrbutton { background-color: #50b848; border: none; color: white; padding: 8px 32px; text-align: center; text-decoration: none; display: inline-block; font-size: 1.3em; margin: 16px auto 16px auto; border: 2px solid #e7e7e7; border-radius:…

Read the full article here

Source: aacrjournals.org

Categories: Oncologists1, General Medicine News

Tweets with this article

Cancer Research

Submit your Research Article or Resource Report to Cancer Research’s special series—Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI—launching in July 2025. Learn more: https://t.co/GasUi4HcYJ https://t.co/roI0cVU7G7

Related Articles

Clinical trial researching immunotherapy for cervical cancer

A clinical trial led by James L. Gulley, M.D., Ph.D., Co-Director of the Center for Immuno-Oncology, is researching combination immunotherapy for cervical cancer.

National Cancer Institute January 15, 2025

GSK’227 Gets FDA Breakthrough Therapy Designation for Advanced Osteosarcoma

GSK5764227 has been granted FDA breakthrough therapy designation, potentially expediting its development as a treatment for relapsed/refractory osteosarcoma.

Oncology Nursing News January 15, 2025

Hema Now: Episode 8: What’s Next in Lymphoma Diagnosis and Treatment?

Uncover the future of lymphoma care with Marc Hoffman, Professor, Hematologic Malignancies at the University of Kansas Medical Center.

EMJ Hematology January 15, 2025

Starting the year smarter

To start the year right, Fred Hutch scientists, providers and a patient advocate share tips to help readers keep up with the deluge of health…

Fred Hutch January 15, 2025

Care Packages and Connection: A Local Group’s Efforts Bring Joy to Cancer Patients

Members of the Keith Dawson Foundation visited the Fox Chase-Temple University Hospital Bone Marrow Transplant Unit at TUH-Jeanes Campus in late December to share goodies…

Fox Chase Cancer Center January 15, 2025

Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms

The biology of cancer is characterized by an intricate interplay of cells originating not only from the tumor mass, but also its surrounding environment. Different…

International Journal of Cancer January 15, 2025

Real-world outcomes with bispecific T-cell engagers in lymphoma worse than pivotal trials

SAN DIEGO — Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings achieved worse survival outcomes than those…

HemOnc Today January 15, 2025

Treatment of focal anaplastic Wilms tumor: A report from the Children’s Oncology Group AREN0321 and AREN03B2 studies

Outcomes are reported for patients with stage I–IV focal anaplastic Wilms tumor (FAWT) treated in the Children’s Oncology Group (COG) AREN0321 study or enrolled in…

ACS Journal Cancer January 15, 2025

Victoria’s Secret Global Fund for Women’s Cancers Career Development Awards, in Partnership with Pelotonia & AACR

$206,000 over two years for female assistant professors conducting research with a direct applicability and relevance to the understanding, prevention, interception, early detection, diagnosis, or…

AACR January 15, 2025

FDA Approval Sought for TAR-200 in BCG-Unresponsive High-Risk NMIBC With CIS

An NDA has been submitted to the FDA seeking the approval of TAR-200 for BCG-unresponsive high-risk NMIBC with CIS, with or without papillary tumors.

OncLive.com January 15, 2025